In the case of tumor bearing mice, these increased splenic percentages, in response to MVA-TWIST/TRICOM administration, correlated with increased tumor infiltration of CD8+ T cells, as well as effector and central CD8+ T cells even in the absence of altered total lymphocytic infiltration (Figure 4A and 4B). Here, CD8A is linked to neoplasm.